Choong Ang Vaccine Laboratory Co., Ltd.

KOSDAQ:A072020 Stock Report

Market Cap: ₩96.4b

Choong Ang Vaccine Laboratory Valuation

Is A072020 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A072020 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A072020 (₩10050) is trading above our estimate of fair value (₩3972.46)

Significantly Below Fair Value: A072020 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A072020?

Key metric: As A072020 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for A072020. This is calculated by dividing A072020's market cap by their current book value.
What is A072020's PB Ratio?
PB Ration/a
Book₩96.09b
Market Cap₩96.35b

Price to Book Ratio vs Peers

How does A072020's PB Ratio compare to its peers?

The above table shows the PB ratio for A072020 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average0.6x
A330350 WITHUS PHARMACEUTICALLTD
1xn/a₩89.0b
A183490 Enzychem Lifesciences
0.6xn/a₩102.8b
A009300 Sam-A Pharm
0.5xn/a₩107.4b
A004720 PharmGen Science
0.4xn/a₩85.2b
A072020 Choong Ang Vaccine Laboratory
n/an/a₩96.4b

Price-To-Book vs Peers: Insufficient data to calculate A072020's Price-To-Book Ratio vs. peers for valuation analysis.


Price to Book Ratio vs Industry

How does A072020's PB Ratio compare vs other companies in the KR Pharmaceuticals Industry?

0 CompaniesPrice / BookEstimated GrowthMarket Cap
A072020 is unprofitableIndustry Avg. 1.1xNo. of Companies13PB00.81.62.43.24+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: Insufficient data to calculate A072020's Price-To-Book Ratio vs. industry for valuation analysis.


Price to Book Ratio vs Fair Ratio

What is A072020's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A072020 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ration/a
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate A072020's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies